TTK and cancer: To determine the most likely mechanism of how reversine acts on cells, we compared its profile in cell proliferation assays on a panel of sixty-six cancer cell lines (OncolinesTM) with those of 122 clinical and pre-clinical anti-cancer agents, including several selective TTK and Aurora kinase inhibitors [41].